Chicago, Illinois
CNS trials open to children and teens in Chicago, IL
12 CNS studies open to children and teens are recruiting participants at sites in Chicago as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Chicago at a glance
- 12 studies are recruiting at a site in Chicago.
- By phase: Phase 1/2 (1), Phase 3 (8), No phase (3). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (9), university, hospital or other (3).
- By research area: Depression (4), Migraine (3), Schizophrenia (3), Epilepsy (2).
- Most recent update to one of these records: November 18, 2026.
Depression studies recruiting in Chicago
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Our Voices Matter: Intervention for Depression in Youth
- No phase
- Ages 15 to 20
- All sexes
- Sponsor
- Seattle Children's Hospital
- Study site
- Ann & Robert H. Lurie Children's Hospital of Chicago
- Registry record
- NCT07216326 · updated
Rise & Thrive: Community-Engagement Intervention for Stress and Depression in Youth.
- No phase
- Ages 15 to 20
- All sexes
- Sponsor
- Seattle Children's Hospital
- Study site
- Ann & Robert H. Lurie Children's Hospital of Chicago
- Registry record
- NCT07554326 · updated
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Ann & Robert H. Lurie Children's Hospital of Chicago
- Registry record
- NCT06372964 · updated
Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury
- No phase
- Ages 14 to 18
- All sexes
- Sponsor
- Northwestern University
- Study site
- Northwestern University
- Registry record
- NCT07224165 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Chicago, IL on ClinicalTrials.gov.
Epilepsy studies recruiting in Chicago
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Encoded Therapeutics
- Study site
- Ann & Robert H. Lurie Children's Hospital of Chicago
- Registry record
- NCT05419492 · updated
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Phase 3
- From 1 day, up to 18 years
- All sexes
- Sponsor
- Praxis Precision Medicines
- Study site
- Praxis Research Site
- Registry record
- NCT07019922 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Chicago, IL on ClinicalTrials.gov.
Migraine studies recruiting in Chicago
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Chicago Headache Center & Research Institute
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Chicago Headache Center & Research Institute
- Registry record
- NCT04743141 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Chicago Headache Center & Research Institute /ID# 248625
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Chicago, IL on ClinicalTrials.gov.
Schizophrenia studies recruiting in Chicago
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Phase 3
- Ages 13 to 17
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- EmVenio Research Center - Prime Healthcare
- Registry record
- NCT07288567 · updated
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- EmVenio Research Center - Prime Healthcare
- Registry record
- NCT07424404 · updated
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigator Site
- Registry record
- NCT05303064 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Chicago, IL on ClinicalTrials.gov.
Ask about studies near Chicago
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections